64 results
8-K
EX-10.3
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
, improvement or innovation, whether or not patentable or capable of registration, and whether or not recorded in any medium.
page 10 of 13
You acknowledge
8-K
EX-10.4
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
premises or resources).
"Invention" means any invention, idea, discovery, development, improvement or innovation, whether or not patentable or capable
8-K
EX-10.2
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
or innovation, whether or not patentable or capable of registration, and whether or not recorded in any medium.
page 10 of 13
You acknowledge
424B3
ADAP
Adaptimmune Therapeutics Plc
20 Apr 23
Prospectus supplement
4:32pm
company will be located in key innovation hubs and will have a deep bench of cell therapy professionals, infrastructure and end-to-end capabilities … will have greater expertise and technology access, which will allow Adaptimmune to accelerate innovation and sustain investment in rapid product
S-4/A
txii852 lzflb59
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
S-4
xli8cj 52
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
j23x6z
15 Jun 22
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-10.1
g5a0a2thpve45
15 Jun 22
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-10.2
iqydufaefmi7rp2llaq
15 Jun 22
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-99.1
rph5ek54mhabs
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
8-K
EX-10.1
mj69puxlo bspgumzjpl
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
8-K
p3lyezt iha8v9k
20 Aug 21
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-10.2
beqm0tcs j3qu0x
20 Aug 21
Entry into a Material Definitive Agreement
4:31pm
8-K
EX-10.1
u7g697i t3up36t
20 Aug 21
Entry into a Material Definitive Agreement
4:31pm